Pharmacology & ToxicologyFrontiers in Cell and Developmental BiologyPeer-reviewed
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.
Carly R. Cabel, Briana A. Guzman, Elaheh Alizadeh…·Curtis A. Thorne
This study uses high-throughput screens in human cells with authentic SARS-CoV-2 virus to identify neutralizing monoclonal antibodies and kinase inhibitors with minimal host toxicity.